RadNet (RDNT) is back in focus after its DeepHealth subsidiary commercially launched Reporting Pro, an AI powered radiology tool that combines speech recognition, AI generated findings, and quality checks within a single workflow.

Despite a 1-day share price return that declined 1.6% to about US$67.83, RadNet has seen strong short term momentum with a 7-day share price return of 10% and a 30-day share price return of 24.8%. The 1-year total shareholder return of 22.6% and 3-year total shareholder return of about 114% indicate investors who stayed the course have been rewarded, even as the stock was recently dropped from several Russell value benchmarks.

If AI in radiology is on your radar, this is a good moment to broaden your watchlist and look at 40 healthcare AI stocks

RadNet now trades at about a 31% discount to one estimate of intrinsic value and roughly 32% below the average analyst target, even after its recent run. Is that a margin of safety, or a signal of market caution?

Most Popular Narrative: 24.4% Undervalued

RadNet’s most followed narrative points to a fair value of about $89.75 versus the recent $67.83 share price, framing Reporting Pro within a much larger AI and imaging expansion story.

Ongoing investments in AI-powered imaging solutions (e.g., DeepHealth, See-Mode, iCAD) are materially increasing center throughput, boosting capacity utilization, and driving more high-margin advanced procedures, directly enhancing both revenue growth and EBITDA margins as adoption scales through 2026.

Want to see what sits behind that confidence in RadNet? The narrative leans on faster revenue compounding, margin rebuild from losses, and a future earnings multiple far above the sector. The exact mix of growth, profitability, and required return is where the story really gets interesting.

Result: Fair Value of $89.75 (UNDERVALUED)

However, RadNet’s AI and imaging expansion story still depends on two pressure points: reimbursement outcomes and the risk that heavy AI and acquisition spending will weigh on cash generation.

Next Steps

Mixed messages in the RadNet story so far? Take a moment to weigh both sides of the argument, then act quickly to shape your own view by reviewing the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond RadNet?

Do not stop with RadNet alone. Use this moment to line up your next potential moves with a few focused stock ideas built from clear, data driven filters.

• Target potential mispricings by scanning for companies that combine quality fundamentals with muted expectations using the 45 high quality undervalued stocks.
• Build stability into your watchlist by zeroing in on businesses with strong finances through the solid balance sheet and fundamentals stocks screener (47 results).
• Get ahead of the crowd by scouting lesser known opportunities with solid numbers using the screener containing 18 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.